Isotretinoin's discovery and development series

Oct 15, 2015, 4:00am

Dr. Jim Leyden, an active participant in isotretinoin's drug development process, discusses many of the important initial clinical observations and those that others have made over the years.

 

 

 

Dermatology Times editorial advisor, Dr. Elaine Siegfried talks with Jim Leyden, M.D., emeritus professor of dermatology at the University of Pennsylvania about the art and science of isotretinoin therapy. Dr. Leyden, an active participant in the drug development process, discusses many of the important initial clinical observations and those that others have made over the years.

READ: Full Interview

 

 

 

 

 

Dermatology Times editorial advisor, Dr. Elaine Siegfried  discusses isotretinoin dosing and side effects with Jim Leyden, M.D., emeritus professor of dermatology at the University of Pennsylvania. Listen in and learn more.

READ: Full interview

 


 

 

 

 

Dermatology Times editorial advisor, Dr. Elaine Siegfried and Jim Leyden, M.D., emeritus professor of dermatology at the University of Pennsylvania discuss distinguishing sinus tracts or keratinous cysts from nodular areas of inflammation and techniques for treating via intralesional injection.

READ: Full interview

 

 

 

 

 

Dermatology Times editorial advisor, Dr. Elaine Siegfried and Jim Leyden, M.D., emeritus professor of dermatology at the University of Pennsylvania discuss whether a waiting period is necessary before treating acne scars and the questionable existence of pityrosporum folliculitis.

READ: Full interview